The LSU AgCenter has finalized its agreement with GB Sciences Louisiana LLC, a wholly owned subsidiary of GB Sciences, Inc., to produce medical cannabis products for qualifying patients in Louisiana.
Southern University’s Agricultural Research and Extension Center and the LSU AgCenter hold the only Louisiana licenses for medical marijuana under authorization approved by the state Legislature and signed by then Gov. Bobby Jindal in 2015.
Southern is down to three finalists in their search for a producer, Advanced Biomedics and Med Louisiana from Lafayette, and Southern Roots Therapeutics from Baton Rouge.
In compliance with the Alison Neustrom Act (Act 261) approved medical care providers will oversee patients with debilitating conditions, including cancer, HIV, epilepsy and spasticity.
GB Sciences will produce medical cannabis under the LSU AgCenter’s license for patients with very specific conditions that include chronic pain and heart therapies as well as chronic arthritis, Crohn’s disease, inflammatory bowel disease and asthma.
Practitioners may recommend medical cannabis through specific delivery methods and dosages to patients who have exhausted other medical options without a positive result.
“It is extremely important that we can provide patients with safe and consistent options to help improve their quality of life,” said Bill Richardson, LSU vice president for agriculture.
The LSU AgCenter has been working closely with state regulators — including the Louisiana Department of Agriculture and Forestry, the Louisiana Board of Pharmacy and the Louisiana State Board of Medical Examiners — to ensure patient and public safety.